Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024 16:05 ET
|
Evoke Pharma, Inc.
Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in net revenue for 2024 SOLANA BEACH, Calif., March 14, 2024 ...
NEURONES : + 11,1% de croissance organique en 2023
February 07, 2024 11:40 ET
|
NEURONES
INFORMATION PRESSERubrique : C.A. annuel 2023 Nanterre, le 7 février 2024 (après Bourse) + 11,1% de croissance organique en 2023 (en cours d’audit, en M€)20222023Croissancedont...
NEURONES: 11.1% organic growth in 2023
February 07, 2024 11:40 ET
|
NEURONES
PRESS INFORMATIONHeading: 2023 annual revenues Nanterre, February 7, 2024 (after trading) 11.1% organic growth in 2023 (being audited, in € millions)20222023Growthof which...
ROSEN, THE FIRST FILING FIRM, Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – PAYC
November 19, 2023 13:20 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
NATIONALLY RANKED ROSEN LAW FIRM Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – PAYC
November 16, 2023 13:55 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
Osisko publie ses résultats du troisième trimestre de 2023
November 08, 2023 17:00 ET
|
Redevances Aurifères Osisko Ltée
MONTRÉAL, 08 nov. 2023 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (la « Société » ou « Osisko ») (TSX et NYSE : OR) annonce aujourd’hui ses résultats financiers consolidés pour le...
Osisko Reports Q3 2023 Results
November 08, 2023 17:00 ET
|
Osisko Gold Royalties Ltd.
MONTREAL, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) today announced its consolidated financial results for the third quarter of...
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update
November 08, 2023 16:11 ET
|
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results
NEURONES : + 12,3% de croissance organique en cumul à la fin du 3e trimestre 2023
November 08, 2023 11:40 ET
|
NEURONES
INFORMATION PRESSERubrique : C.A. 3e trimestre 2023 Nanterre, le 8 novembre 2023 (après Bourse) + 12,3% de croissance organique en cumul à la fin du 3e trimestre 2023 (non audités, en millions...
NEURONES: Organic growth up 12.3% over the first nine months of the year
November 08, 2023 11:40 ET
|
NEURONES
PRESS INFORMATIONHeading: 3rd quarter 2023 revenues Nanterre, November 8, 2023 (after trading) Organic growth up 12.3% over the first nine months of the year (not audited, in millions of...